Factors related to rapid progression of non‐small cell lung cancer in Chinese patients treated using single‐agent immune checkpoint inhibitor treatment

Factors related to rapid progression of non‐small cell lung cancer in Chinese patients treated using single‐agent immune checkpoint inhibitor treatment

Abstract Background Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of non‐small cell lung cancer (NSCLC). While rapid progression (RP) has been proposed as a non‐negligible pattern of response to ICIs, its definition and related factors remain unclear. This study aimed to deve...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang Zhang, Lianwei Bai, Xianhong Liu, Ying Liu, Shuang Li, Jingjing Liu, Shuang Zhang, Changliang Yang, Xiubao Ren, Ying Cheng
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:Thoracic Cancer
Subjects:
Immune checkpoint inhibitor
non‐small cell lung cancer
rapid progression
Online Access:https://doi.org/10.1111/1759-7714.13370
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items